high dose semaglutide Photo | high-dose injection pens on table Healthy Returns: Novo Nordisk releases

The results were clear: Patients on 15 mg of tirzepatide lost an average of 11.2 kg (~24.7 lbs)

Its that, with GLP-1s, the user still has a big role to play in their effectiveness

Parenteral administration, which includes subcutaneous injections, is the most common route for GLP-1 receptor agonists

Researchers concluded that those taking tirzepatide were significantly more likely to achieve weight loss, but added that more studies are needed to better understand the full range of benefits and effects both drugs have on patients

doi:10.1139/H08-00 Ashtary-Larky D, Ghanavati M, Lamuchi-Deli N, et al

On the nutrition side, protein leads